Comparative Analysis of Endocarditis in Congenital Heart Disease Patients Across Age Groups: Endocarditis in Congenital Heart Disease Patients Across Age Groups

Muhammad Naeem; Fazal Ur Rehman; Umar Shafiq; Ussama Munir; Muhammad Adnan Zafar; Iftikhar Ahmad

doi:10.54393/pjhs.v6i6.3176

Authors

Muhammad Naeem Department of Pediatrics, Quaid-e-Azam Medical College, Bahawalpur, Pakistan
Fazal Ur Rehman Department of Pediatrics Cardiology, Quaid-e-Azam Medical College, Bahawalpur, Pakistan
Umar Shafiq Department of Pediatrics, Quaid-e-Azam Medical College, Bahawalpur, Pakistan
Ussama Munir Department of Cardiology, Quaid-e-Azam Medical College, Bahawalpur, Pakistan
Muhammad Adnan Zafar Department of Pediatrics, Quaid-e-Azam Medical College, Bahawalpur, Pakistan
Iftikhar Ahmad Department of Pediatrics, Quaid-e-Azam Medical College, Bahawalpur, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v6i6.3176

Keywords:

Congenital Heart Defects, Endocarditis, Microbiology, Mortality, Socioeconomic Factors

Abstract

Infective endocarditis remains a serious complication in patients with congenital heart disease, yet age-related differences in presentation and outcomes are not well understood. Objectives: To evaluate age-stratified clinical characteristics, microbiological profiles, and in-hospital outcomes of infective endocarditis (IE) in patients with congenital heart disease (CHD), with emphasis on diagnostic patterns and mortality predictors. Methods: This cross-sectional analytical study was conducted at the Department of Cardiology, Quaid-e-Azam Medical College, Bahawalpur, from March 2024 to March 2025. A total of 113 patients with CHD and definite IE, diagnosed per modified Duke criteria, were enrolled through non-probability consecutive sampling. Patients were stratified into two groups: ≤18 years (n=57) and >18 years (n=56). Data on demographics, clinical variables, blood culture results, inflammatory markers, echocardiographic findings, and in-hospital outcomes were collected. Results: Septal defects were significantly more common in children (61.4%) versus adults (p=0.0288). Adults exhibited higher mean creatinine (1.21±0.42 mg/dL vs 0.96 ± 0.28 mg/dL, p=0.032) and vegetation size (10.4 ± 4.2 mm vs 8.6 ±2 .9 mm, p=0.031). In-hospital mortality was 12.4%. Vegetation size >10 mm and prosthetic material presence were significant mortality predictors (adjusted OR=4.23, 95% CI: 1.63–10.99, p=0.001; and OR=3.45, 95% CI: 1.19–9.83, p=0.009). Blood culture positivity reduced mortality risk (adjusted OR=0.53, 95% CI: 0.22–0.91, p=0.001). Conclusions: Adult CHD patients with IE presented with more advanced disease and higher mortality risk, especially with prosthetic material and large vegetations.

References

Havers-Borgersen E, Østergaard L, Holgersson CK, Stahl A, Schmidt MR, Smerup M et al. Infective Endocarditis with or without Congenital Heart Disease: Clinical Features and Outcomes. European Heart Journal. 2024 Nov; 45(44): 4704-15. doi: 10.1093/eurheartj/ehae548. DOI: https://doi.org/10.1093/eurheartj/ehae548

van Melle JP, Roos-Hesselink JW, Bansal M, Kamp O, Meshaal M, Pudich J, Luksic VR et al. Infective Endocarditis in Adult Patients with Congenital Heart Disease. International Journal of Cardiology. 2023 Jan; 370: 178-85.

Ong LT and Low FJ. Incidence and Predictive Factors of Mortality of Infective Endocarditis in Adults with Congenital Heart Disease: A Systematic Review and Meta-Analysis. International Journal of Cardiology. 2024 Sep; 410: 132237. doi: 10.1016/j.ijcard.2024.132237. DOI: https://doi.org/10.1016/j.ijcard.2024.132237

Borrelli N, Sabatino J, Gimelli A, Avesani M, Pergola V, Leo I et al. Multimodality Imaging Approach to Infective Endocarditis: Current Opinion in Patients with Congenital Heart Disease. Journal of Clinical Medicine. 2025 Mar; 14(6): 1862. doi: 10.3390/jcm14061862. DOI: https://doi.org/10.3390/jcm14061862

Carvajal V, Reyes FB, Gonzalez D, Schwartz M, Whiltlow A, Alegria JR. Endocarditis in Adult Congenital Heart Disease Patients: Prevention, Recognition, and Management. Current Cardiology Reports. 2024 Sep; 26(9): 1031-45. doi: 10.1007/s11886-024-02103-9. DOI: https://doi.org/10.1007/s11886-024-02103-9

Fedchenko M, Giang KW, Snygg-Martin U, Dellborg M, Mandalenakis Z. Risk and Predictors of First-Time Infective Endocarditis in Adult Patients with Congenital Heart Disease—A Nationwide, Register-Based Study. International Journal of Cardiology. 2025 May; 426: 133081. doi: 10.1016/j.ijcard.2025.133081. DOI: https://doi.org/10.1016/j.ijcard.2025.133081

Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG et al. Epidemiology, Characteristics, and Outcome of Infective Endocarditis in Italy: The Italian Study on Endocarditis. Infection. 2012 Oct; 40(5): 527-35. doi: 10.1007/s15010-012-0285-y. DOI: https://doi.org/10.1007/s15010-012-0285-y

Brida M, Balint HO, Bence A, Panfile E, Prokšelj K, Kačar P et al. Infective Endocarditis in Adults with Congenital Heart Disease: Contemporary Management and Related Outcomes in Central and South-Eastern European Region. International Journal of Cardiology. 2023 Apr; 377: 45-50. doi: 10.1016/j.ijcard.2023.01.012. DOI: https://doi.org/10.1016/j.ijcard.2023.01.012

Moscatelli S, Leo I, Bianco F, Surkova E, Pezel T, Donald NA et al. The Role of Multimodality Imaging in Patients with Congenital Heart Disease and Infective Endocarditis. Diagnostics. 2023 Dec; 13(24): 3638. doi: 10.3390/diagnostics13243638. DOI: https://doi.org/10.3390/diagnostics13243638

Vicent L, Goenaga MA, Muñoz P, Marín-Arriaza M, Valerio M, Fariñas MC et al. Infective Endocarditis in Children and Adolescents: A Different Profile with Clinical Implications. Pediatric Research. 2022 Nov; 92(5): 1400-6. doi: 10.1038/s41390-022-01959-3. DOI: https://doi.org/10.1038/s41390-022-01959-3

Snygg-Martin U, Giang KW, Dellborg M, Robertson J, Mandalenakis Z. Cumulative Incidence of Infective Endocarditis in Patients with Congenital Heart Disease: A Nationwide, Case-Control Study Over Nine Decades. Clinical Infectious Diseases. 2021 Oct; 73(8): 1469-75. doi: 10.1093/cid/ciab478. DOI: https://doi.org/10.1093/cid/ciab478

Abdel-Haq N, Shawaqfeh A, Gupta S, Ang JY, Thomas R, Asmar BI. Infective Endocarditis at a Referral Children’s Hospital During 19-Year Period: Trends and Outcomes. Pediatric cardiology. 2024 Dec; 45(8): 1741-9. doi: 10.1007/s00246-023-03274-y. DOI: https://doi.org/10.1007/s00246-023-03274-y

Di Filippo S. Clinical Outcomes for Congenital Heart Disease Patients Presenting with Infective Endocarditis. Expert Review of Cardiovascular Therapy. 2020 Jun; 18(6): 331-42. doi: 10.1080/14779072.2020.1768847. DOI: https://doi.org/10.1080/14779072.2020.1768847

Havers-Borgersen E, Butt JH, Østergaard L, Petersen JK, Torp-Pedersen C, Køber L et al. Long-term Incidence of Infective Endocarditis among Patients with Congenital Heart Disease. American Heart Journal. 2023 May; 259: 9-20. doi: 10.1016/j.ahj.2023.01.012. DOI: https://doi.org/10.1016/j.ahj.2023.01.012

Baltimore RS, Gewitz M, Baddour LM, Beerman LB, Jackson MA, Lockhart PB et al. Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement from the American Heart Association. Circulation. 2015 Oct; 132(15): 1487-515. doi: 10.1161/CIR.0000000000000298. DOI: https://doi.org/10.1161/CIR.0000000000000298

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al. 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2014 Jun; 63(22): e57-185. doi: 10.1016/j.jacc.2014.02.536. DOI: https://doi.org/10.1161/CIR.0000000000000031

Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Zotti FD et al. 2015 ESC Guidelines for the Management of Infective Endocarditis. Revista Española de Cardiología (English Edition). 2016; 69(1). doi: 10.1016/j.rec.2015.12.002. DOI: https://doi.org/10.1016/j.rec.2015.12.002

Thornhill MH, Dayer MJ, Prendergast B, Baddour LM, Jones S, Lockhart PB. Incidence and Nature of Adverse Reactions to Antibiotics Used as Endocarditis Prophylaxis. Journal of Antimicrobial Chemotherapy. 2015 Aug; 70(8): 2382-8. doi: 10.1093/jac/dkv115. DOI: https://doi.org/10.1093/jac/dkv115

Moore B, Cao J, Kotchetkova I, Celermajer DS. Incidence, Predictors and Outcomes of Infective Endocarditis in A Contemporary Adult Congenital Heart Disease Population. International Journal of Cardiology. 2017 Dec; 249: 161-5. doi: 10.1016/j.ijcard.2017.08.035. DOI: https://doi.org/10.1016/j.ijcard.2017.08.035

Mylotte D, Rushani D, Therrien J, Guo L, Liu A, Guo K et al. Incidence, Predictors, and Mortality of Infective Endocarditis in Adults with Congenital Heart Disease Without Prosthetic Valves. The American Journal of Cardiology. 2017 Dec; 120(12): 2278-83. doi: 10.1016/j.amjcard.2017.08.051. DOI: https://doi.org/10.1016/j.amjcard.2017.08.051